Sprint Bioscience AB - ESG Rating & Company Profile powered by AI
The assessment of Sprint Bioscience AB employs intelligence from across the web and also from public filings by Sprint Bioscience AB. The report of Sprint Bioscience AB was assembled by All Street Sevva using leading NLP. The page is a zero-cost Environmental, Social and Governance analysis for Sprint Bioscience AB.
Sprint Bioscience AB in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.6; made up of an environmental score of 0.0, social score of 8.0 and governance score of 2.7.
3.6
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1132 | Taro Pharmaceutical Industries Ltd | 3.7 | Medium |
1132 | Traphaco JSC | 3.7 | Medium |
1144 | Sprint Bioscience AB | 3.6 | Medium |
1144 | CellSeed Inc | 3.6 | Medium |
1144 | Cellectar Biosciences Inc | 3.6 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Sprint Bioscience AB have an accelerator or VC vehicle to help deliver innovation?
Does Sprint Bioscience AB disclose current and historical energy intensity?
Does Sprint Bioscience AB report the average age of the workforce?
Does Sprint Bioscience AB reference operational or capital allocation in relation to climate change?
Does Sprint Bioscience AB disclose its ethnicity pay gap?
Does Sprint Bioscience AB disclose cybersecurity risks?
Does Sprint Bioscience AB offer flexible work?
Does Sprint Bioscience AB have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Sprint Bioscience AB disclose the number of employees in R&D functions?
Does Sprint Bioscience AB conduct supply chain audits?
Does Sprint Bioscience AB disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Sprint Bioscience AB conduct 360 degree staff reviews?
Does Sprint Bioscience AB disclose the individual responsible for D&I?
Does Sprint Bioscience AB disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Sprint Bioscience AB disclose current and / or historical scope 2 emissions?
Does Sprint Bioscience AB disclose water use targets?
Does Sprint Bioscience AB have careers partnerships with academic institutions?
Did Sprint Bioscience AB have a product recall in the last two years?
Does Sprint Bioscience AB disclose incidents of discrimination?
Does Sprint Bioscience AB allow for Work Councils/Collective Agreements to be formed?
Has Sprint Bioscience AB issued a profit warning in the past 24 months?
Does Sprint Bioscience AB disclose parental leave metrics?
Does Sprint Bioscience AB disclose climate scenario or pathway analysis?
Does Sprint Bioscience AB disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Sprint Bioscience AB disclose the pay ratio of women to men?
Does Sprint Bioscience AB support suppliers with sustainability related research and development?
Does Sprint Bioscience AB disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Sprint Bioscience AB reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Sprint Bioscience AB involved in embryonic stem cell research?
Does Sprint Bioscience AB disclose GHG and Air Emissions intensity?
Does Sprint Bioscience AB disclose its waste policy?
Does Sprint Bioscience AB report according to TCFD requirements?
Does Sprint Bioscience AB disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Sprint Bioscience AB disclose energy use targets?
Does Sprint Bioscience AB disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Sprint Bioscience AB have a policy relating to cyber security?
Have a different question?
Potential Risks for Sprint Bioscience AB
These potential risks are based on the size, segment and geographies of the company.
Sprint Bioscience AB (publ) develops pharmaceutical products in the areas of cancer and metabolism in Sweden, Europe, the United States, and Asia. It engages in developing VPS34, a drug candidate for the treatment of various types of cancer; and PETRA01, a drug candidate for the treatment of cancer. The company also focuses on research of products for the treatment of tumor metabolism and type 2 diabetes. Sprint Bioscience AB (publ) was founded in 2009 and is based in Huddinge, Sweden.